Skip to main content
Signal8

BRANCACCIO JOHN P

SEC insider (Form 3/4/5 filer). CIK 0001276551. Director at OKYO Pharma Ltd (OKYO). 3 reported Form 4/5 transactions since Sep 2024; latest on Jul 21, 2026. Located in LONDON.

Companies BRANCACCIO JOHN P has filed insider reports for

  • OKYO Pharma Ltd (OKYO): Director
BRANCACCIO JOHN P profile photo

BRANCACCIO JOHN P

CIK: 0001276551

Transaction Breakdown

Open Market Buys (P)1 (33.3%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (66.7%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

OKYO Pharma Ltd logo
OKYO

OKYO Pharma Ltd

Director

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • OKYO Pharma Ltd logo
    OKYO

    OKYO Pharma Ltd

    Jul 21, 2026
    Purchase
    Direct
    5K shares at avg. $1.48$7K
  • OKYO Pharma Ltd logo
    OKYO

    OKYO Pharma Ltd

    Jul 21, 2026
    Award
    Direct
    5K shares at avg. $1.48$7K
  • OKYO Pharma Ltd logo
    OKYO

    OKYO Pharma Ltd

    Jun 8, 2026
    Award

    Option

    Direct
    6.5K shares at avg. $1.85-

1-3 of 3